Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
143 studies found for:    Sjogren's Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Sjogren's Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Low Dose Cyclosporin A in Primary Sjögren Syndrome
Condition: Sjögren´s Syndrome
Intervention: Drug: Cyclosporine A
2 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active - Cohort 1;   Drug: CFZ533 placebo- Cohort 1;   Drug: CFZ533 active - Cohort 2;   Drug: CFZ533 placebo - Cohort 2
3 Completed A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
Conditions: Dry Mouth Associated With Sjogren's Syndrome;   Xerostomia
Interventions: Drug: Placebo;   Drug: 552-02
4 Completed Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention: Drug: Mycophenolate sodium
5 Not yet recruiting Safety, Pharmacokinetics, and Preliminary Efficacy Study of CDZ173 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CDZ173;   Drug: Placebo
6 Active, not recruiting PD of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736;   Drug: Placebo
7 Unknown  Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)
Conditions: Sjogren's Syndrome;   Mesenchymal Stem Cells
Intervention: Biological: Allogeneic Mesenchymal Stem Cells (AlloMSC)
8 Recruiting A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Matching Placebo;   Drug: RO5459072
9 Recruiting A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: AMG 557/MEDI5872;   Other: Placebo
10 Completed Neurotrophins Implications in Primary Sjögren Syndrome
Condition: Primary Sjögren Syndrome
Intervention: Biological: blood sample
11 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
12 Recruiting Implantology and Sjögren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Device: Biohorizons Laser-lok bonelevel dental implants
13 Recruiting UCB Proof of Concept Study in Patients With Primary Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Interventions: Drug: UCB5857;   Drug: Placebo
14 Completed Efficacy and Safety of Belimumab in Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: LimphoStat-B
15 Recruiting Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
16 Recruiting Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: SS-1;   Drug: Placebo
17 Completed Etanercept Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Etanercept
18 Completed Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Belimumab
19 Terminated
Has Results
Pilot Study of Raptiva to Treat Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Raptiva
20 Withdrawn Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Conditions: Primary Sjogren's Syndrome;   Secondary Sjogren's Syndrome;   Inflammatory Arthritis;   Rheumatoid Arthritis
Intervention: Drug: Abatacept

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.